Business Context and Reporting Period
Company: Intelligent Bio Solutions Inc. (INBS)
Filing Type: Form 8-K (Current Report)
Date of Report: February 13, 2025
Reporting Period: Fiscal quarter ended December 31, 2024
Context: The Company filed this report to announce financial results for the quarter ended December 31, 2024, via a press release furnished as Exhibit 99.1.
Key Financial Metrics
The provided filing text serves as a cover document referencing a press release (Exhibit 99.1) but does not contain specific numerical data. Consequently, the following metrics are not available in the source text:
- Revenue: Not provided in filing text.
- Profit/Loss: Not provided in filing text.
- Cash Flow: Not provided in filing text.
- Margins: Not provided in filing text.
- Debt and Liquidity: Not provided in filing text.
Material Changes
The filing text does not provide specific comparative data or details regarding material changes versus the prior comparable period. Investors must refer to the attached press release (Exhibit 99.1) for this information.
Guidance, Outlook, and Risks
Guidance and Outlook: The filing text does not contain management commentary, forward-looking guidance, or specific outlook statements.
Risks and Contingencies: No specific risks or contingencies are detailed in the body of this 8-K filing.
Unusual Items: No unusual items are described in the provided text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated February 13, 2025) for actual revenue, net income, and cash flow figures for the quarter ended December 31, 2024.
- Verify year-over-year and quarter-over-quarter performance metrics in the press release, as they are absent from the 8-K summary text.
- Check for any updated forward-looking guidance or operational milestones mentioned in the press release.
- Confirm the Company's status as an Emerging Growth Company (indicated as checked in the filing) and its implications for financial reporting standards.